Related Experiment Video

Updated: May 22, 2026

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells
10:28

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells

Published on: January 10, 2018

2-Hydroxyoleate, a nontoxic membrane binding anticancer drug, induces glioma cell differentiation and autophagy

Silvia Terés1, Victoria Lladó, Mónica Higuera

  • 1Molecular Cell Biomedicine, Department of Biology-Institut Universitari d'Investigacions en Ciències de la Salut, University of the Balearic Islands, 07122 Palma de Mallorca, Spain.

Proceedings of the National Academy of Sciences of the United States of America
|May 16, 2012
PubMed

Insights

2-hydroxyoleic acid (2OHOA) offers a promising new treatment for glioma, inducing cell differentiation and autophagy. This novel therapy is more effective than temozolomide (TMZ) and prevents tumor relapse, offering hope for improved patient outcomes.

Area of Science:

  • Neuro-oncology
  • Cancer Cell Biology
  • Molecular Medicine

Background:

  • Glioma treatment options remain limited, with minimal improvement in patient survival over the last three decades.
  • Temozolomide (TMZ) is the current standard therapy, but its efficacy is often insufficient, and tumor relapse is common.

Purpose of the Study:

  • To investigate the therapeutic potential of 2-hydroxyoleic acid (2OHOA) in human glioma cells.
  • To elucidate the mechanism of action of 2OHOA in combating glioma.

Main Methods:

  • Treatment of human glioma cells with 2OHOA and comparison with temozolomide (TMZ).
  • Analysis of changes in membrane-lipid composition, including sphingomyelin (SM) levels.
  • Assessment of signaling pathway modulation, including Ras translocation, MAP kinase, PI3K/Akt, and Cyclin D-CDK4/6/RB pathways.
  • Evaluation of glioma cell differentiation and induction of autophagic cell death.

Main Results:

  • 2-hydroxyoleic acid (2OHOA) demonstrated superior efficacy compared to temozolomide (TMZ) in combating glioma.
  • Unlike TMZ, 2OHOA treatment led to the absence of tumor relapse.
  • 2OHOA treatment restored sphingomyelin (SM) levels, reduced Ras membrane localization, inhibited MAP kinase and PI3K/Akt pathways, and downregulated Cyclin D-CDK4/6, leading to RB hypophosphorylation.
  • These molecular changes induced glioma cell differentiation and subsequent autophagic cell death.

Conclusions:

  • 2-hydroxyoleic acid (2OHOA) is a novel therapeutic agent that effectively induces glioma cell differentiation and autophagic cell death.
  • 2OHOA's mechanism involves restoring membrane lipid composition and modulating key oncogenic signaling pathways.
  • With its high efficacy, low toxicity, oral bioavailability, and brain penetration, 2OHOA represents a promising new therapeutic strategy for glioma patients.

More Related Videos

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...